NCT06720064Recruiting
Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters
Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheter-Related Bloodstream Infections in Pediatric Cancer Patients
Source: ClinicalTrials.gov · Last updated 6 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections". These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 18 Sept 2024
- Start date
- 7 May 2024
- Primary completion date
- Dec 2025
- Lead sponsor
- Dokuz Eylul University
- Diseases
- Childhood cancers
- NCT number
- NCT06720064
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 7 May 2024 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have a systemic infection.
Who the study is looking for
- The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit
- The child has a diagnosis of hematological or oncological cancer
- The child's age range is between 1 and 17
- Having a port catheter inserted and no early complications have occurred
- The child agrees to participate in the study voluntarily
- The parent agrees to participate in the study voluntarily
- Obtaining the consent form from the child and parent
- He has been in the hospital for more than 48 hours
Age in the registry: 1 year to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gülçin Özalp Gerçeker Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.